UPLOAD Filing
Werewolf Therapeutics, Inc.
Date: May 12, 2025 · CIK: 0001785530 · Accession: 0000000000-25-005026
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287078
Letter
Re: Werewolf Therapeutics, Inc. Registration Statement on Form S-3 Filed May 8, 2025 File No. 333-287078 Dear Daniel Hicklin Ph.D.:
May 12, 2025
Daniel Hicklin, Ph.D. Chief Executive Officer Werewolf Therapeutics, Inc. 200 Talcott Avenue, 2nd Floor Watertown, MA 02472
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Stephanie Leopold, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 12, 2025 Daniel Hicklin, Ph.D. Chief Executive Officer Werewolf Therapeutics, Inc. 200 Talcott Avenue, 2nd Floor Watertown, MA 02472 Re: Werewolf Therapeutics, Inc. Registration Statement on Form S-3 Filed May 8, 2025 File No. 333-287078 Dear Daniel Hicklin Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stephanie Leopold, Esq. </TEXT> </DOCUMENT>